HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis

被引:0
作者
Kyung-Eun Lee
Sung-Eun Choi
Haimuzi Xu
Ji-Hyoun Kang
Dong-Jin Park
Shin-Seok Lee
机构
[1] Chonnam National University Medical School and Hospital,Department of Rheumatology
来源
Rheumatology International | 2017年 / 37卷
关键词
Rheumatoid arthritis; Remission; Predictor; Physical function;
D O I
暂无
中图分类号
学科分类号
摘要
We assessed potential predictors of sustained remission for 2 years according to the Disease Activity Score in 28 joints (DAS28)-CRP in patients with rheumatoid arthritis (RA). We obtained data for 290 RA outpatients, from July 2009 to September 2012. Sociodemographic data and answers to questionnaires were collected in face-to-face interviews. Remission was defined according to DAS28-CRP. Sustained remission was defined as meeting criteria for remission in the annual assessment for two consecutive years. Predictive factors of sustained remission according to DAS28-CRP were assessed by univariate and multivariate analyses. Of the 290 RA patients, the baseline remission level, according to DAS28-CRP, was 54.5%. During 2 years of follow-up, the sustained remission rate was 24.5%. RA patients who achieved sustained remission, according to DAS28-CRP, were younger, and had a shorter duration of symptoms, longer period of education, higher monthly income, lower Health Assessment Questionnaire (HAQ) score, lower physician global assessment, lower patient global assessment, lower patient pain assessment, and higher EQ-5D at baseline. Multivariate analyses showed that the baseline HAQ score was independently associated with sustained remission for 2 years according to DAS28-CRP (OR 0.298, 95% CI 0.115–0.770; p = 0.012). A lower HAQ score at baseline was an independent predictor of sustained remission at 2 years, according to DAS28-CRP. Thus, HAQ scores could be useful when stratifying patients according to risk for flare-ups in the clinic.
引用
收藏
页码:2027 / 2034
页数:7
相关论文
共 225 条
[1]  
Smolen JS(2010)Treating rheumatoid arthritis to target: recommendations of an international task force Ann Rheum Dis 69 631-637
[2]  
Aletaha D(2014)Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs Arthritis Res Ther 16 R56-1453
[3]  
Bijlsma JW(2010)Remission in early rheumatoid arthritis J Rheumatol 37 1444-1143
[4]  
Breedveld FC(2010)Predictors for remission in rheumatoid arthritis patients: a systematic review Arthritis Care Res (Hoboken) 62 1128-729
[5]  
Boumpas D(2015)Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort Ann Rheum Dis 74 724-686
[6]  
Burmester G(2015)Physical function continues to improve when clinical remission is sustained in rheumatoid arthritis patients Arthritis Res Ther 17 203-793
[7]  
Combe B(2012)Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort Ann Rheum Dis 71 681-1613
[8]  
Cutolo M(2017)Factors associated with sustained remission in rheumatoid arthritis in patients treated with anti-tumor necrosis factor Arthritis Care Res (Hoboken) 69 783-1609
[9]  
de Wit M(2014)The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy J Rheumatol 41 1607-175
[10]  
Dougados M(2016)Predictors and outcomes of sustained, intermittent or never achieving remission in patients with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register Rheumatology 55 1601-324